Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1080/14786419.2020.1839452

http://scihub22266oqcxt.onion/10.1080/14786419.2020.1839452
suck pdf from google scholar
33121282!ä!33121282
PDF vom PMID33121282  :  Publisher

suck abstract from ncbi

pmid33121282
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Potential of Ficus microcarpa metabolites against SARS-CoV-2 main protease supported by docking studies #MMPMID33121282
  • Hassan HA; Abdelmohsen UR; Aly OM; Desoukey SY; Mohamed KM; Kamel MS
  • Nat Prod Res 2020[Oct]; ä (ä): 1-5 PMID33121282show ga
  • COVID 19; an infectious disease; firstly identified in December 2019 in Wuhan, China and has since spread globally, resulting in an ongoing pandemic. Searching for protease inhibitors is a challenging task in controlling COVID 19. Genus Ficus is known to be a rich source of phenolic compounds. Metabolic profiling of leaves methanolic extract of Ficus microcarpa (Moraceae) revealed nine compounds (1-9) mainly phenolics. Docking studies concerning these compounds against SARS-CoV-2 main protease showed that quercetin 3,7-O-alpha-L-dirhamnoside (1) and rutin (3) possessed significant binding stability at the N3 binding site in different activity degrees, which is comparable with COVID-19 main protease inhibitor, darunavir. Our study suggests that compounds quercetin 3,7-O-alpha-L-dirhamnoside and rutin might be potential candidates for the development of therapies against SARS-CoV-2.
  • ä


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    1 ä.ä 2020